Cargando…
Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials
INTRODUCTION: The administration of methylprednisolone (MP) is a component of perioperative multimodal analgesia that mitigates the potentially deleterious effects of postoperative pain and opioid consumption. However, a systematic evaluation of the efficacy and safety of MP is lacking. The present...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845491/ https://www.ncbi.nlm.nih.gov/pubmed/36260278 http://dx.doi.org/10.1007/s40122-022-00443-4 |
_version_ | 1784870911527092224 |
---|---|
author | Fu, Xi Ye, Xin An, Li-Na Jiang, Hua Huang, Wen-Bo Huang, Ya Dong, Jing Ren, Yi-Feng |
author_facet | Fu, Xi Ye, Xin An, Li-Na Jiang, Hua Huang, Wen-Bo Huang, Ya Dong, Jing Ren, Yi-Feng |
author_sort | Fu, Xi |
collection | PubMed |
description | INTRODUCTION: The administration of methylprednisolone (MP) is a component of perioperative multimodal analgesia that mitigates the potentially deleterious effects of postoperative pain and opioid consumption. However, a systematic evaluation of the efficacy and safety of MP is lacking. The present systematic review and meta-analysis was performed to quantify the potential clinical benefits and risks of perioperative MP in lung surgery. METHODS: We searched seven electronic databases for randomized controlled trials (RCTs) comparing MP with placebo. Coprimary outcomes were rest pain scores, dynamic pain scores, and cumulative morphine equivalent consumption within 24 h postoperatively. RESULTS: A total of 11 trials including 643 participants were selected for our meta-analysis. The results demonstrated that the MP group had a significant difference in coprimary outcomes (rest pain scores, dynamic pain scores, and cumulative morphine equivalent consumption) compared with the placebo group; nevertheless, the improvement was not clinically meaningful based on minimum clinically important differences (MCID). Notably, MP administration reduced serum levels of interleukin (IL)-6 at 6 h (weighted mean difference −20.49 pg/mL; 95% CI −29.94 to −11.04), and decreased the incidence rate of acute lung injury (rate ratio 0.18; 95% CI 0.03–0.98) and cognitive dysfunction (rate ratio 0.43; 95% CI 0.21–0.88) compared with the placebo group. CONCLUSIONS: Our findings suggest that the administration of MP contributed to an insignificant relief in acute postoperative pain for lung surgery in a clinical setting. Future studies should focus on exploring the role of MP in reducing pulmonary and surgical-related complications after lung surgery. CLINICAL TRIAL NUMBER: PROSPERO registration number CRD42022314224. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-022-00443-4. |
format | Online Article Text |
id | pubmed-9845491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-98454912023-01-19 Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials Fu, Xi Ye, Xin An, Li-Na Jiang, Hua Huang, Wen-Bo Huang, Ya Dong, Jing Ren, Yi-Feng Pain Ther Original Research INTRODUCTION: The administration of methylprednisolone (MP) is a component of perioperative multimodal analgesia that mitigates the potentially deleterious effects of postoperative pain and opioid consumption. However, a systematic evaluation of the efficacy and safety of MP is lacking. The present systematic review and meta-analysis was performed to quantify the potential clinical benefits and risks of perioperative MP in lung surgery. METHODS: We searched seven electronic databases for randomized controlled trials (RCTs) comparing MP with placebo. Coprimary outcomes were rest pain scores, dynamic pain scores, and cumulative morphine equivalent consumption within 24 h postoperatively. RESULTS: A total of 11 trials including 643 participants were selected for our meta-analysis. The results demonstrated that the MP group had a significant difference in coprimary outcomes (rest pain scores, dynamic pain scores, and cumulative morphine equivalent consumption) compared with the placebo group; nevertheless, the improvement was not clinically meaningful based on minimum clinically important differences (MCID). Notably, MP administration reduced serum levels of interleukin (IL)-6 at 6 h (weighted mean difference −20.49 pg/mL; 95% CI −29.94 to −11.04), and decreased the incidence rate of acute lung injury (rate ratio 0.18; 95% CI 0.03–0.98) and cognitive dysfunction (rate ratio 0.43; 95% CI 0.21–0.88) compared with the placebo group. CONCLUSIONS: Our findings suggest that the administration of MP contributed to an insignificant relief in acute postoperative pain for lung surgery in a clinical setting. Future studies should focus on exploring the role of MP in reducing pulmonary and surgical-related complications after lung surgery. CLINICAL TRIAL NUMBER: PROSPERO registration number CRD42022314224. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-022-00443-4. Springer Healthcare 2022-10-19 2023-02 /pmc/articles/PMC9845491/ /pubmed/36260278 http://dx.doi.org/10.1007/s40122-022-00443-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Fu, Xi Ye, Xin An, Li-Na Jiang, Hua Huang, Wen-Bo Huang, Ya Dong, Jing Ren, Yi-Feng Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials |
title | Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials |
title_full | Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials |
title_fullStr | Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials |
title_full_unstemmed | Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials |
title_short | Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials |
title_sort | efficacy and safety of methylprednisolone for lung surgery: a systematic review and meta-analysis of randomized controlled trials |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845491/ https://www.ncbi.nlm.nih.gov/pubmed/36260278 http://dx.doi.org/10.1007/s40122-022-00443-4 |
work_keys_str_mv | AT fuxi efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT yexin efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT anlina efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT jianghua efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT huangwenbo efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT huangya efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT dongjing efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT renyifeng efficacyandsafetyofmethylprednisoloneforlungsurgeryasystematicreviewandmetaanalysisofrandomizedcontrolledtrials |